Early Efficacy of Ferric Carboxymaltose (Ferinject®) in Patients with Iron-Deficiency Anemia: Single Institution Experience
September 2018
Studysummary In this retrospective study, all-female patients with iron deficiency anemia treated with ferric carboxymaltose experienced rapid symptom resolution and increased ferritine and hemoglobin levels, with some reporting manageable side effects such as rash and headache.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on morressier.com →